Onconetix (ONCO) 10-Q2023 Q2 Quarterly report

Filed: 20 Oct 23, 5:12pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: Abbott, absconded, absorb, academic, accreted, accurate, acknowledgment, adhere, ads, advertising, advisor, Air, alerted, amortizable, amortization, amortized, analyst, APS, arose, artificial, attention, automated, Baltimore, beneficiary, bfw, bid, bioAffinity, Bruce, Campbell, card, Cardinal, cardiology, Celera, Channel, Chapter, CODM, concentrated, confidential, constituted, contemplated, contravention, copy, counsel, court, creditor, culture, Dale, deciding, decision, decline, Default, device, difficulty, disagreement, disciplinary, discovery, disposition, dispute, distinct, Doctorate, document, documentation, Duquesne, entertainment, EntreMed, Environmental, eradicate, eventual, exploration, face, facilitated, finite, Food, forfeited, formulary, forward, founder, fraudulent, Garfield, gift, goal, good, goodwill, green, Harbor, Harmon, healthtech, hereof, HKUST, human, IGEN, imposition, improper, imputed, ineligible, inextricably, ingredient, injunctive, intangible, intelligence, intervention, inventory, invoking, Jeremic, Jon, Joseph, journal, Lakeport, leaked, led, linked, litigation, Liverpool, loan, lose, lower, mailed, maker, manipulation, Marizyme, marketplace, misconduct, Mississippi, Missouri, misuse, monetary, nanotechnology, Neil, network, Norwich, NY, oncology, online, otic, outlined, pain, parent, past, Patriax, paused, Payer, PBM, penny, permissible, Pharma, pharmacy, PIO, posting, power, precautionary, prepay, prescription, pressure, Programm, proper, properly, proposed, prospect, prospective, quorum, quotation, reassigned, receipt, recoup, recovery, recruiting, regain, regularly, reliable, remit, resolve, resolved, resumed, retirement, retroactive, returnable, reveal, Roche, sabotage, salary, Sapirstein, secondary, segment, shareholder, shelf, short, SOW, spectrum, stagger, step, stringent, subsidiary, suitability, suitable, SuperNova, Tech, Tennessee, theft, therapeutic, thereon, thereunder, trivial, UK, unallocated, unauthorized, underperformance, undiscounted, unintended, unlawful, unsecured, unvested, UpScriptHealth, vendor, venture, veteran, VIE, volume, voluntarily, Vuk, waiting, warehouse, website, Webster, wholesaler, wraser, wrote, Xspire, York

Removed: acquire, acute, authoritative, BWV, determinable, discover, duration, economy, epidemic, exacerbate, flu, institution, investigated, legally, liquidity, magnitude, media, pivotal, prevailing, space, ultimate, uncertain, updated, utilized, validate

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ONCO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION OF THE

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Blue Water Biotech, Inc. (the “Company”) for the quarterly period ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Bruce Harmon, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: October 20, 2023	By:	/s/ Bruce Harmon
		Bruce Harmon
		Chief Financial Officer
		(Principal Financial Officer)